Anne Ghys

474 total citations
11 papers, 354 citations indexed

About

Anne Ghys is a scholar working on Hepatology, Infectious Diseases and Epidemiology. According to data from OpenAlex, Anne Ghys has authored 11 papers receiving a total of 354 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hepatology, 8 papers in Infectious Diseases and 8 papers in Epidemiology. Recurrent topics in Anne Ghys's work include Hepatitis C virus research (11 papers), HIV/AIDS drug development and treatment (8 papers) and Hepatitis B Virus Studies (7 papers). Anne Ghys is often cited by papers focused on Hepatitis C virus research (11 papers), HIV/AIDS drug development and treatment (8 papers) and Hepatitis B Virus Studies (7 papers). Anne Ghys collaborates with scholars based in United States, Belgium and Germany. Anne Ghys's co-authors include Sandra De Meyer, Inge Dierynck, Gastón Picchio, James C. Sullivan, Tara L. Kieffer, Stefan Zeuzem, Maria Beumont, Doug J. Bartels, Eileen Z. Zhang and Ann M. Tigges and has published in prestigious journals such as PLoS ONE, Hepatology and Clinical Infectious Diseases.

In The Last Decade

Anne Ghys

11 papers receiving 353 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Anne Ghys United States	7	343	285	186	20	19	11	354
U. Karey Germany	5	323 0.9×	259 0.9×	160 0.9×	26 1.3×	15 0.8×	6	339
Krishna Chodavarapu United States	8	335 1.0×	292 1.0×	103 0.6×	27 1.4×	11 0.6×	10	346
Rob Elston United States	5	292 0.9×	263 0.9×	103 0.6×	23 1.1×	25 1.3×	7	323
Evguenia Svarovskaia United States	7	328 1.0×	294 1.0×	139 0.7×	21 1.1×	5 0.3×	14	339
Michèle Martinot France	9	419 1.2×	418 1.5×	57 0.3×	13 0.7×	13 0.7×	15	461
Eileen Z. Zhang United States	8	529 1.5×	407 1.4×	303 1.6×	41 2.0×	31 1.6×	10	544
Elena Losada Spain	6	225 0.7×	206 0.7×	160 0.9×	18 0.9×	96 5.1×	9	312
Satomi Iwasaki Japan	13	458 1.3×	436 1.5×	91 0.5×	29 1.4×	4 0.2×	22	519
Chia Wang United States	6	364 1.1×	345 1.2×	58 0.3×	10 0.5×	28 1.5×	11	450
T. Santantonio Italy	8	677 2.0×	656 2.3×	74 0.4×	11 0.6×	13 0.7×	17	709

Countries citing papers authored by Anne Ghys

Since Specialization

Citations

This map shows the geographic impact of Anne Ghys's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anne Ghys with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anne Ghys more than expected).

Fields of papers citing papers by Anne Ghys

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Anne Ghys. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anne Ghys. The network helps show where Anne Ghys may publish in the future.

Co-authorship network of co-authors of Anne Ghys

This figure shows the co-authorship network connecting the top 25 collaborators of Anne Ghys. A scholar is included among the top collaborators of Anne Ghys based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Anne Ghys. Anne Ghys is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

11 of 11 papers shown

Lathouwers, Erkki, et al.. (2020). Week 96 resistance analyses of the once‐daily, single‐tablet regimen (STR) darunavir/cobicistat/emtricitabine/tenofovir alafenamide (D/C/F/TAF) in adults living with HIV‐1 from the phase 3 randomized AMBER and EMERALD trials. Journal of Medical Virology. 93(6). 3985–3990. 2 indexed citations

Sarrazin, Christoph, Erkki Lathouwers, Monika Peeters, et al.. (2015). Prevalence of the hepatitis C virus NS3 polymorphism Q80K in genotype 1 patients in the European region. Antiviral Research. 116. 10–16. 82 indexed citations

Süsser, S., H. W. Reesink, Stefan Zeuzem, et al.. (2015). Evolution of Hepatitis C Virus Quasispecies during Repeated Treatment with the NS3/4A Protease Inhibitor Telaprevir. Antimicrobial Agents and Chemotherapy. 59(5). 2746–2755. 10 indexed citations

Sarrazin, Christoph, Inge Dierynck, Gavin Cloherty, et al.. (2015). An OPTIMIZE Study Retrospective Analysis for Management of Telaprevir-Treated Hepatitis C Virus (HCV)-Infected Patients by Use of the Abbott RealTi m e HCV RNA Assay. Journal of Clinical Microbiology. 53(4). 1264–1269. 11 indexed citations

Picchio, Gastón, Sandra De Meyer, Inge Dierynck, et al.. (2014). Patterns of viral load decline with telaprevir-based therapy in patients with genotype 1 chronic HCV infection. Journal of Clinical Virology. 59(3). 148–155. 1 indexed citations

Meyer, Sandra De, Anne Ghys, Inge Dierynck, et al.. (2014). Virologic characterization of genotype 4 hepatitis C virus variants in patients treated with telaprevir. Virology Journal. 11(1). 93–93. 4 indexed citations

Haseltine, Eric L., Sandra De Meyer, Inge Dierynck, et al.. (2014). Modeling Viral Evolutionary Dynamics after Telaprevir-Based Treatment. PLoS Computational Biology. 10(8). e1003772–e1003772. 6 indexed citations

Dierynck, Inge, Kim Thys, Anne Ghys, et al.. (2014). Deep-Sequencing Analysis of the Gene Encoding the Hepatitis C Virus Nonstructural 3–4A Protease Confirms a Low Prevalence of Telaprevir-Resistant Variants at Baseline and the End of the REALIZE Study. The Journal of Infectious Diseases. 210(12). 1871–1880. 15 indexed citations

Sullivan, James C., Sandra De Meyer, Doug J. Bartels, et al.. (2013). Evolution of Treatment-Emergent Resistant Variants in Telaprevir Phase 3 Clinical Trials. Clinical Infectious Diseases. 57(2). 221–229. 114 indexed citations

10.

Meyer, Sandra De, Inge Dierynck, Anne Ghys, et al.. (2012). Characterization of telaprevir treatment outcomes and resistance in patients with prior treatment failure: Results from the REALIZE trial. Hepatology. 56(6). 2106–2115. 35 indexed citations

11.

Kieffer, Tara L., Sandra De Meyer, Doug J. Bartels, et al.. (2012). Hepatitis C Viral Evolution in Genotype 1 Treatment-Naïve and Treatment-Experienced Patients Receiving Telaprevir-Based Therapy in Clinical Trials. PLoS ONE. 7(4). e34372–e34372. 74 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact